Clinical Trial Update: Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease [NA]

View source ↗

Summary

The trial investigating pulsatile intravenous insulin for Alzheimer's disease and mild cognitive impairment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Pulsatile intravenous insulin (insulin)

Snippet

Sponsor: Louisiana State University Health Sciences Center Shreveport | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | NA | Status: WITHDRAWN